AU2003252318A1 - Regulator for mental disease risk fragility - Google Patents

Regulator for mental disease risk fragility

Info

Publication number: AU2003252318A1
Authority: AU; Australia
Prior art keywords: fragility; regulator; disease risk; mental disease; mental
Prior art date: 2002-08-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003252318A

Inventor

Yasushi Kajii

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mitsubishi Tanabe Pharma Corp

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-09

Filing date

2003-08-01

Publication date

2004-02-25

2003-08-01 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2004-02-25 Publication of AU2003252318A1 publication Critical patent/AU2003252318A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003252318A 2002-08-09 2003-08-01 Regulator for mental disease risk fragility Abandoned AU2003252318A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002-232448		2002-08-09
JP2002232448		2002-08-09
PCT/JP2003/009796 WO2004014429A1 (en)	2002-08-09	2003-08-01	Regulator for mental disease risk fragility

Publications (1)

Publication Number	Publication Date
AU2003252318A1 true AU2003252318A1 (en)	2004-02-25

Family

ID=31711832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003252318A Abandoned AU2003252318A1 (en)	2002-08-09	2003-08-01	Regulator for mental disease risk fragility

Country Status (3)

Country	Link
JP (1)	JPWO2004014429A1 (en)
AU (1)	AU2003252318A1 (en)
WO (1)	WO2004014429A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en)	2017-10-09	2025-11-04	Compass Pathfinder Limited	Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
CN113993522A (en)	2019-04-17	2022-01-28	指南针探路者有限公司	Method for treating anxiety disorders, headache disorders and eating disorders with siloxibin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0450757A3 (en) *	1990-02-22	1993-09-15	Glaxo Group Limited	Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
JP2002515435A (en) *	1998-05-21	2002-05-28	イーライ・リリー・アンド・カンパニー	Combination therapy for treatment of depression
US6740672B1 (en) *	1998-12-22	2004-05-25	Novartis Pharma Gmbh	Use of 5HT3-receptor antagonists for the treatment of chronic fatigue syndrome

2003
- 2003-08-01 AU AU2003252318A patent/AU2003252318A1/en not_active Abandoned
- 2003-08-01 WO PCT/JP2003/009796 patent/WO2004014429A1/en not_active Ceased
- 2003-08-01 JP JP2004527324A patent/JPWO2004014429A1/en active Pending

Also Published As

Publication number	Publication date
WO2004014429A1 (en)	2004-02-19
JPWO2004014429A1 (en)	2005-12-02

Publication	Publication Date	Title
AU2003284472A1 (en)	2004-06-18	Warm poultice
AU2003209268A1 (en)	2003-09-02	Calendar overlays
EP2295053B8 (en)	2018-03-28	Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003259221A1 (en)	2004-02-16	Reward system
AU2003294559A1 (en)	2004-07-09	Database for allowing multiple customized views
TW595562U (en)	2004-06-21	Casket
AU2003286608A1 (en)	2004-05-13	Managing biological databases
GB2393267B (en)	2006-05-17	Diffractive optical elements
AU2003286767A1 (en)	2004-07-29	Gravitational pressure regulating mechanism
AU2003292622A1 (en)	2004-07-22	Optical sensor
AU2003296124A1 (en)	2004-07-22	Optical sensor
AU2003283252A1 (en)	2004-04-19	Lingual retainer
AU2003243623A1 (en)	2003-12-31	Calendar
AU2003274836A1 (en)	2004-01-06	Compensation device
AU2003280803A1 (en)	2004-06-15	Optical sensor
AU2003273810A1 (en)	2004-03-19	Regulating device
AU2003252318A1 (en)	2004-02-25	Regulator for mental disease risk fragility
AU2003252339A1 (en)	2004-02-23	Optical sensor
GB0209254D0 (en)	2002-06-05	Preparation for the relief of disease
AU2003304540A1 (en)	2004-06-06	Illuminator
AU2003212741A1 (en)	2003-09-16	Light diffraction
AU2003267558A1 (en)	2004-03-19	Blood regulation device
AU2003260986A1 (en)	2005-02-25	Ear-pick for otoscopes
AU2003264855A1 (en)	2004-04-19	Insurance plan
AU2003227659A1 (en)	2003-11-03	Microspectrometer

Legal Events

Date	Code	Title	Description
2005-04-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase